Meeting
2016 ASCO Annual Meeting
Neoadjuvant chemotherapy versus chemoradiation prior to esophagectomy: Impact on rate of complete pathologic response and survival in esophageal cancer patients.
Authors
Albert C. Lockhart
Washington University School of Medicine in St. Louis, St. Louis, MO
Albert C. Lockhart , Pamela Parker Samson , Cliff Grant Robinson , Jeffrey D. Bradley , Varun Puri , Stephen R. Broderick , G Alexander Patterson , Bryan F Meyers , Traves Crabtree
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4054)
DOI
10.1200/JCO.2016.34.15_suppl.4054
Abstract #
4054
Poster Bd #
46
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Delineating longitudinal patterns of response to neoadjuvant systemic therapy (NAST) in triple-negative breast cancer (TNBC): Profiling results from a randomized, TNBC enrolling trial to confirm molecular profiling improves survival (ARTEMIS; NCT02276443).
First Author: Sahil Seth
Poster
2019 Gastrointestinal Cancers Symposium
The association of 5FU-based chemotherapy with pathological response or survival compared to carbo/taxol with locally advanced resectable esophageal cancer.
First Author: Mohammed Al-Jumayli
Poster
2019 Gastrointestinal Cancers Symposium
Timing after neoadjuvant therapy predicts mortality in patients undergoing esophagectomy.
First Author: Taylor Maramara
Poster
2018 Gastrointestinal Cancers Symposium
Postoperative chemotherapy in patients who are pN+ following neoadjuvant chemoradiation for locally advanced esophageal cancer.
First Author: Samual Francis